化学
赫拉
蛋白质酪氨酸磷酸酶
癌症研究
癌症
变构调节
癌细胞
细胞生物学
细胞凋亡
生物化学
磷酸化
细胞
磷酸酶
酶
生物
遗传学
作者
Mengzhu Zheng,Yang Liu,Canrong Wu,Kaiyin Yang,Qiqi Wang,Yirong Zhou,Lixia Chen,Hua Li
标识
DOI:10.1016/j.bioorg.2021.104788
摘要
Protein tyrosine phosphatase SHP2 is a member of PTPs family associated with cancer such as leukemia, non-small cell lung cancer, breast cancer, and so on. SHP2 is a promising target for drug development, and consequently it is of great significance to develop SHP2 inhibitors. Herein, we report CRBN-recruiting PROTAC molecules targeting SHP2 by connecting pomalidomide with SHP099, an allosteric inhibitor of SHP2. Among them, SP4 significantly inhibited the growth of Hela cells, compared with SHP099, its activity increased 100 times. In addition, it can significantly induce SHP2 degradation and cell apoptosis. Further study of SHP2-protac may have important significance for the treatment of SHP2 related diseases.
科研通智能强力驱动
Strongly Powered by AbleSci AI